|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 157.10 EUR | +1.29% |
|
+3.83% | +32.02% |
| 06-05 | HC Wainwright Starts Ipsen Coverage with Buy Rating | MT |
| 06-02 | Fulcrum plummets over 50% after scrapping lead sickle-cell drug on FDA concerns | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IPSEN | Other Pharmaceuticals | +1.29% | +3.83% | +32.02% | +49.48% | +70.21% | 14.71B |  |  | |
- Stock Market
- Stocks
- IPN Stock
- Charts Ipsen
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
